NCT00060502View on ClinicalTrials.gov

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia

PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

February 28, 2006

Conditions
CachexiaPancreatic Neoplasms
Interventions
DRUG

Infliximab; Gemcitabine

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY